Global Manufacturing Presence Sirio Pharma operates state-of-the-art manufacturing facilities across the United States, Germany, and China, offering ample capacity and proximity to key markets which can facilitate rapid and flexible production for international clients seeking high-quality nutraceutical products.

Strategic Acquisition Expansion The company's recent acquisition of Best Formulations strengthens its manufacturing capabilities and geographic reach, particularly in North America, presenting opportunities to offer expanded product development and manufacturing services to clients targeting growth in these regions.

Product Innovation Focus With expertise in diverse delivery formats such as gummies, softgels, powders, and functional beverages, Sirio Pharma can serve clients seeking innovative, customized nutraceutical solutions, opening doors for tailored product development collaborations.

Market Position & Revenue Generating between $100 million and $250 million in revenue with a sizable workforce, Sirio Pharma's strong market position and financial stability make it a reliable partner for large-scale manufacturing contracts and long-term partnerships in the nutraceutical industry.

Industry Focus & Growth As a leading global CDMO with an emphasis on quality and innovation, Sirio Pharma presents opportunities for partnership with brands looking to outsource manufacturing or develop new products, especially in the rapidly growing health and wellness sector.